Literature DB >> 9395250

Prothymosin alpha promotes cell proliferation in NIH3T3 cells.

C L Wu1, A L Shiau, C S Lin.   

Abstract

Thymic hormones have immunomodulatory effects on T cells and hence have been used clinically to restore the immunity of immunodeficient patients as well as to enhance the cellular immunity of cancer patients. Prothymosin alpha, which is a member of the thymic hormone family, has recently been suggested to act as a nuclear protein participating in the stimulation of cell proliferation. To characterize the biological activities ofprothymosin alpha in vitro, we established NIH3T3 cell transformants that constitutively express higher prothymosin alpha protein and its mRNA compared with the wild-type counterpart. Cells that overexpressed prothymosin alpha increased the proliferative activity assayed by the [3H]-thymidine incorporation or by the cell cycle analysis with the fluorescent-activated cell sorter. The results provide direct evidence that prothymosin alpha plays a role in cell proliferation by shortening the duration of the G1 phase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395250     DOI: 10.1016/s0024-3205(97)00882-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Novel strategy for generation and titration of recombinant adeno-associated virus vectors.

Authors:  Ai-Li Shiau; Pu-Ste Liu; Chao-Liang Wu
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.

Authors:  Ruben N Karapetian; Alexandra G Evstafieva; Irina S Abaeva; Nina V Chichkova; Grigoriy S Filonov; Yuri P Rubtsov; Elena A Sukhacheva; Sergey V Melnikov; Ulrich Schneider; Erich E Wanker; Andrey B Vartapetian
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 5.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

6.  Apoptotic and proliferating hepatocytes differ in prothymosin alpha expression and cell localization.

Authors:  Luciana Barbini; Rosario Gonzalez; Fernando Dominguez; Felix Vega
Journal:  Mol Cell Biochem       Date:  2006-07-15       Impact factor: 3.396

7.  Transgenic expression of prothymosin alpha on zebrafish epidermal cells promotes proliferation and attenuates UVB-induced apoptosis.

Authors:  Chiung-Wen Pai; Yau-Hung Chen
Journal:  Transgenic Res       Date:  2009-12-11       Impact factor: 2.788

8.  Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.

Authors:  Yuh-Shyan Tsai; Yeong-Chin Jou; Chun-Liang Tung; Chang-Te Lin; Cheng-Huang Shen; Syue-Yi Chen; Hsin-Tzu Tsai; Chen-Li Lai; Chao-Liang Wu; Tzong-Shin Tzai
Journal:  Virchows Arch       Date:  2014-04-15       Impact factor: 4.064

9.  Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.

Authors:  Jason S Knight; Ke Lan; Chitra Subramanian; Erle S Robertson
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Prothymosin α overexpression contributes to the development of pulmonary emphysema.

Authors:  Bing-Hua Su; Yau-Lin Tseng; Gia-Shing Shieh; Yi-Cheng Chen; Ya-Chieh Shiang; Pensee Wu; Kuo-Jung Li; Te-Hsin Yen; Ai-Li Shiau; Chao-Liang Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.